Sánchez R M, Vázquez M, Alegret M, Viñals M, Adzet T, Merlos M, Laguna J C
Department of Pharmacology, Faculty of Pharmacy, University of Barcelona, Spain.
Life Sci. 1993;52(2):213-22. doi: 10.1016/0024-3205(93)90142-p.
The effect of fibric acid derivatives, clofibric acid (CFB), bezafibrate (BFB), and gemfibrozil (GFB) on hepatic cytosolic enzymatic activities involved in saturated fatty acid synthesis has been estudied in vitro. From all the activities tested (fatty acid synthetase, acetyl-CoA carboxylase, ATP-citrate lyase, malic enzyme, malic dehydrogenase, glucose-6-phosphate dehydrogenase, and 6-phosphogluconate dehydrogenase), only acetyl-CoA carboxylase and glucose-6-phosphate dehydrogenase were significantly inhibited by fibrates, with the following order of potency: GFB > BFB > > CFB. The characteristics of the inhibition phenomena (IC50, kinetic analysis, time and protein dependence, etc) and their transcendence to the effects of fibric acid derivatives in vivo are discussed.
已在体外研究了纤维酸衍生物氯贝酸(CFB)、苯扎贝特(BFB)和吉非贝齐(GFB)对参与饱和脂肪酸合成的肝细胞溶质酶活性的影响。在所有测试的活性中(脂肪酸合成酶、乙酰辅酶A羧化酶、ATP-柠檬酸裂解酶、苹果酸酶、苹果酸脱氢酶、葡萄糖-6-磷酸脱氢酶和6-磷酸葡萄糖酸脱氢酶),只有乙酰辅酶A羧化酶和葡萄糖-6-磷酸脱氢酶受到贝特类药物的显著抑制,其效力顺序如下:GFB > BFB >> CFB。讨论了抑制现象的特征(IC50、动力学分析、时间和蛋白质依赖性等)及其与纤维酸衍生物体内作用的相关性。